Grant: Project Grant
Toronto Metropolitan University
$631,125.00
Controlling Glucose Metabolism to Develop Superior Tissue Engineered Cartilage
EF 2018-19
Résumé
Damage to articular cartilage by arthritis or injury is a significant healthcare problem as this tissue cannot repair itself. One potential approach to repair damaged cartilage is to use tissue-engineered cartilage implants. However, despite its great potential, several technical hurdles remain which hinder the efficacy of tissue repair. Recently, we have discovered a novel pathway to improve the growth of engineered cartilage by controlling the way the cells metabolize glucose. Thus, the objective of the proposed study is to harness this effect to create functional engineered cartilage implants suitable for joint repair. In this project, the underlying mechanisms responsible will first be determined and engineered cartilage implants will be created to possess the appropriate structure and properties suitable for implantation. Developed tissue implants will then be assessed in clinically relevant animal models of cartilage repair. Currently, there is no optimal treatment for damaged or diseased cartilage. This research will improve patient quality of life while also reducing healthcare costs associated with conventional therapies. Thus, this project represents a critical step to translate important scientific discoveries to the clinic where, one day it can benefit a significant portion of Canadians. This proposed research also represents a novel, paradigm shifting approach to develop functional engineered cartilage that can be easily produced without the need of sophisticated methods and can be readily adapted to any such approach currently under investigation.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
388693
Name
Waldman Stephen D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Biomedical Engineering
Projecttitle
Controlling Glucose Metabolism to Develop Superior Tissue Engineered Cartilage
Programtype2
Operating Grants
Orgnameinp2
Toronto Metropolitan University
Cihramount2
$631,125
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Cartilage; Cell Culture; Glucose; Hypoxia-Induced Factors; Implantation Models; Metabolism; Osteoarthritis; Pseudo-Hypoxia; Tissue Engineering
Abstract
Damage to articular cartilage by arthritis or injury is a significant healthcare problem as this tissue cannot repair itself. One potential approach to repair damaged cartilage is to use tissue-engineered cartilage implants. However, despite its great potential, several technical hurdles remain which hinder the efficacy of tissue repair. Recently, we have discovered a novel pathway to improve the growth of engineered cartilage by controlling the way the cells metabolize glucose. Thus, the objective of the proposed study is to harness this effect to create functional engineered cartilage implants suitable for joint repair. In this project, the underlying mechanisms responsible will first be determined and engineered cartilage implants will be created to possess the appropriate structure and properties suitable for implantation. Developed tissue implants will then be assessed in clinically relevant animal models of cartilage repair. Currently, there is no optimal treatment for damaged or diseased cartilage. This research will improve patient quality of life while also reducing healthcare costs associated with conventional therapies. Thus, this project represents a critical step to translate important scientific discoveries to the clinic where, one day it can benefit a significant portion of Canadians. This proposed research also represents a novel, paradigm shifting approach to develop functional engineered cartilage that can be easily produced without the need of sophisticated methods and can be readily adapted to any such approach currently under investigation.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Waldman, Stephen D
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $631,125~ $0~